Tempest Therapeutics Inc (NAS:TPST)
$ 1.42 -0.04 (-2.74%) Market Cap: 35.80 Mil Enterprise Value: 24.93 Mil PE Ratio: 0 PB Ratio: 2.05 GF Score: 36/100

Tempest Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2022 / 08:00PM GMT
Release Date Price: $2.08 (-0.48%)
Steve Brady
Tempest Therapeutics, Inc. - CEO

Good afternoon, everyone, and welcome to the 2022 Annual Meeting of Stockholders of Tempest Therapeutics. I'm Steve Brady, Chief Executive Officer of Tempest, and I will act as the Chair of this meeting.

As you know, we are hosting today's meeting through a virtual online platform to support the health and well-being of our stockholders and employees as well as to facilitate stockholder participation. With that in mind, I want to thank you all for taking the time to join us and hope that you are safe and well.

With me today are Tom Dubensky, Tempest President; and Nick Maestas, Tempest Vice President, Strategy and Finance. Nick will also serve as the Secretary of today's meeting.

The meeting will now officially come to order. The time is now 1:00 PM Pacific time on Friday, June 17, 2022, and the polls are now open for voting on all matters to be presented. If you have not yet reviewed the rules of conduct, they can be assessed via the link on the bottom right-hand corner of your screen under the heading Meeting Materials. The rules

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot